
Online
16/12/20
17:00
Bilera honen helburu nagusia SARS-CoV-2 eta COVID-19 azterlanei buruzko gaur egungo ezagutzak eta etorkizuneko orientabideak eguneratzea da.
Webinarrera sartzea doakoa da.
Izen ematea hemen.
PROGRAMA
17:00 Welcome and introductory remarks
Jesús M. Bañales.IIS Biodonostia. San Sebastián, Spain.
Manuel Romero-Gómez. Virgen del Rocío University Hospital. Seville, Spain
Ángeles Pérez Aisa. President of the Andalusian Society of Digestive Pathology
17:05 Role of Host Genetics in COVID-19 severity
Mª Tom Karlsen.. Oslo University Hospital. Oslo, Norway.
17:20 Role of the ABO blood group in SARS-CoV-2 infection and disease
Andre Franke. Institut für Klinische Molekularbiologie. Kiel, Germany.
17:35 Which is the hominin ancestor carrying risk variant haplotypes?
Luca Valenti. University of Milan. Milan, Italy.
17:50 Sequencing SARS-CoV-2 as an opportunity
Federico García. San Cecilio Clinic Hospital. Granada, Spain.
18:05 Personalized and Precision Medicine in COVID-19
Manuel Romero-Gómez.Virgen del Rocío University Hospital. Seville, Spain.
18:20 Panel discussion
Chairman: Jesús M. Bañales.IIS Biodonostia. San Sebastian, Spain.
Agustín Albillos.Ramón y Cajal University Hospital. Madrid, Spain.
Luis Bujanda.IIS Biodonostia. San Sebastián, Spain.
María Buti.Vall d’Hebron Hospital. Barcelona, Spain.
Javier Fernández.Clinic University Hospital. Barcelona, Spain.
18:50 Innovation Research in the management of the pandemic
Isaac Túnez.Secretary General for Research, Development and Innovation. Ministry of Health and Family. Andalusia Regional Government. Spain.
19:00 Concluding remarks